Newstral
Article
metro.us on 2017-02-14 09:46
Actelion, being bought by J&J, says full year core net income rose 27 percent
Related news
- J&J makes takeover approach for Swiss drugmaker Actelion: Bloombergmetro.us
- Actelion re-enters talks with J&J, sidelining SanofiReuters
- Sanofi exploring bid for Actelion amid J&J talks: BloombergReuters
- J&J spends $30 billion on Switzerland's Acteliondothaneagle.com
- FJ&J confirms talks with Actelion over pharma dealft.com
- J&J, Actelion approach Swiss takeover board over deal structure: papermetro.us
- How Sanofi lost out to J&J in $30 billion battle for ActelionReuters
- Exclusive: J&J discussing breaking up Actelion in an acquisition - sourcesReuters
- J&J target Actelion could exit Swiss benchmark SMI index this monthReuters
- Actelion talks to new party, reported to be Sanofi, as J&J drops bidmetro.us
- J&J raises Actelion takeover pressure with higher price: sourceReuters
- J&J tops 1Q profit forecasts, but net dipsThe Salt Lake Tribune
- FSanofi in talks to buy Actelion as J&J bows outft.com
- EHigher core income bolsters NBG profitsekathimerini.com
- Kroger's net income falls 8.6 percentmetro.us
- Novartis CEO plays down prospects for Actelion bid: Blickmetro.us
- MNovartis profit falls, lifts core op. income viewmarketwatch.com
- HSBC sees full-year net income drop by 16 percentdothaneagle.com
- Pennsylvania Adopts Economic Nexus Standard for Corporate Net Income Taxjdsupra.com